VEGFA and retinopathy of prematurity: While Tiryaki et al. [26] and the BEAT-ROP study [31] found lower recurrence rates after anti-VEGF therapy, Walz et al. (21% vs. 19%) and Hwang et al. (16% vs. 3%) reported higher recurrence rates after anti-VEGF compared to laser treatment [24,32].